Difference between revisions of "Chromosomal translocations"
Jump to navigation
Jump to search
m (more refs) |
m (→Lymphoma: more refs) |
||
| Line 109: | Line 109: | ||
|- | |- | ||
| Mantle cell lymphoma | | Mantle cell lymphoma | ||
| | | IGH-CCND1 | ||
| t(11;14) | | t(11;14) | ||
| | | <ref>{{Cite journal | last1 = Li | first1 = JY. | last2 = Gaillard | first2 = F. | last3 = Moreau | first3 = A. | last4 = Harousseau | first4 = JL. | last5 = Laboisse | first5 = C. | last6 = Milpied | first6 = N. | last7 = Bataille | first7 = R. | last8 = Avet-Loiseau | first8 = H. | title = Detection of translocation t(11;14)(q13;q32) in mantle cell lymphoma by fluorescence in situ hybridization. | journal = Am J Pathol | volume = 154 | issue = 5 | pages = 1449-52 | month = May | year = 1999 | doi = 10.1016/S0002-9440(10)65399-0 | PMID = 10329598 }}</ref> | ||
|- | |- | ||
| Burkitt lymphoma | | Burkitt lymphoma | ||
| | | IGH-MYC (???) | ||
| t(8;14) | | t(8;14) | ||
| | | <ref name=pmid19074108>{{Cite journal | last1 = Perkins | first1 = AS. | last2 = Friedberg | first2 = JW. | title = Burkitt lymphoma in adults. | journal = Hematology Am Soc Hematol Educ Program | volume = | issue = | pages = 341-8 | month = | year = 2008 | doi = 10.1182/asheducation-2008.1.341 | PMID = 19074108 }} | ||
</ref> | |||
|- | |- | ||
<!-- | Tumour | <!-- | Tumour | ||
Revision as of 16:52, 20 May 2011
Chromosomal translocations, also translocations, may be characteristic of a tumour or simply narrow down the diagnosis to a set of tumours.
Key point
The key point is:
- One should be aware of the existence of specific (i.e. diagnostic/near diagnostic) translocations and translocations which significantly narrow down the diagnosis -- which are available to (clinical) pathologists.
Unfortunate reality of residency
Translocations are often a subject of pimping and show-up on examinations.
List of translocations
Soft tissue table
| Tumour | Translocation(s) | Genes | Reference(s) |
| Ewing sarcoma/PNET | t(11;22) | FLI1-EWS | [1][2] |
| Myxoid liposarcoma, round-cell type liposarcoma | t(12;16) | CHOP-TLS | [1][3][4] |
| Synovial sarcoma | t(X;18) | SYT-SSX | [1] |
| Alveolar rhabdomyosarcoma | t(1;13) t(2,13) |
PAX7-FKHR PAX3-FKHR |
[1] |
| Extraskeletal myxoid chondrosarcoma | t(9;22) | CHN-EWS | [1] |
| Desmoplastic small round cell tumour | t(11;22) | EWS-WT1 | [1] |
| Clear cell sarcoma | t(12;22) | EWS-ATF1 | [1] |
| Dermatofibrosarcoma protuberans | t(17;22) | COLA1-PDGFB | [1] |
| Alveolar soft part sarcoma | t(X;17) | TFE3-ASPL | [1] |
| Congenital fibrosarcoma | t(12;15) | ETV6-NTRK3 | [1] |
EWS associated
| Tumour | Translocation(s) | Genes | Reference(s) |
| Ewing sarcoma/PNET | t(11;22) | FLI1-EWS | [1][2] |
| Extraskeletal myxoid chondrosarcoma | t(9;22) | CHN-EWS | [1] |
| Desmoplastic small round cell tumour | t(11;22) | EWS-WT1 | [1] |
| Clear cell sarcoma | t(12;22) | EWS-ATF1 | [1] |
Lymphoma
| Tumour | Translocation(s) | Genes | Reference(s) |
| Follicular lymphoma | IGH-BCL2 | t(14,18) | [5] |
| Mantle cell lymphoma | IGH-CCND1 | t(11;14) | [6] |
| Burkitt lymphoma | IGH-MYC (???) | t(8;14) | [7] |
Leukemia
| Tumour | Translocation(s) | Genes | Reference(s) |
| Chronic myelogenous leukemia | BCR-ABL | t(9;22) | [8] |
| Acute promyelocytic leukemia (APL) | PML-RARA | t(15;17) | [9] |
Paediatric table
| Translocation | Genes | Tumour(s) | Reference |
| t(12;16) | FUS/ATF1 | angiomatoid fibrous histiocytoma | [10] |
| t(12;22) | EWS/ATF1 | angiomatoid fibrous histiocytoma | [10] |
| t(12;16) | EWS/CHOP | myxoid liposarcoma | [10] |
| t(16;22) | EWS/ATF1 | myxoid liposarcoma | [10] |
| t(12;22) | EWS/ATF1 | clear cell sarcoma | [10] |
| t(21;22) | EWS/ATF1 | Ewing sarcoma | [10] |
| t(12;21) | FUS/ERG | Ewing sarcoma | [10] |
| t(12;21) | FUS/ERG | acute myeloid leukemia | [10] |
See also
References
- ↑ 1.00 1.01 1.02 1.03 1.04 1.05 1.06 1.07 1.08 1.09 1.10 1.11 1.12 1.13 Kumar, Vinay; Abbas, Abul K.; Fausto, Nelson; Aster, Jon (2009). Robbins and Cotran pathologic basis of disease (8th ed.). Elsevier Saunders. pp. 1249. ISBN 978-1416031215.
- ↑ 2.0 2.1 Online 'Mendelian Inheritance in Man' (OMIM) 133450
- ↑ Antonescu CR, Tschernyavsky SJ, Decuseara R, et al. (December 2001). "Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: a molecular and clinicopathologic study of 82 cases". Clin. Cancer Res. 7 (12): 3977–87. PMID 11751490.
- ↑ Online 'Mendelian Inheritance in Man' (OMIM) 613488
- ↑ Gu, K.; Chan, WC.; Hawley, RC. (Aug 2008). "Practical detection of t(14;18)(IgH/BCL2) in follicular lymphoma.". Arch Pathol Lab Med 132 (8): 1355-61. doi:10.1043/1543-2165(2008)132[1355:PDOBIF]2.0.CO;2. PMID 18684042.
- ↑ Li, JY.; Gaillard, F.; Moreau, A.; Harousseau, JL.; Laboisse, C.; Milpied, N.; Bataille, R.; Avet-Loiseau, H. (May 1999). "Detection of translocation t(11;14)(q13;q32) in mantle cell lymphoma by fluorescence in situ hybridization.". Am J Pathol 154 (5): 1449-52. doi:10.1016/S0002-9440(10)65399-0. PMID 10329598.
- ↑ Perkins, AS.; Friedberg, JW. (2008). "Burkitt lymphoma in adults.". Hematology Am Soc Hematol Educ Program: 341-8. doi:10.1182/asheducation-2008.1.341. PMID 19074108.
- ↑ Cilloni, D.; Saglio, G. (Sep 2009). "CML: a model for targeted therapy.". Best Pract Res Clin Haematol 22 (3): 285-94. doi:10.1016/j.beha.2009.04.004. PMID 19959080.
- ↑ Grimwade, D.; Mistry, AR.; Solomon, E.; Guidez, F. (2010). "Acute promyelocytic leukemia: a paradigm for differentiation therapy.". Cancer Treat Res 145: 219-35. doi:10.1007/978-0-387-69259-3_13. PMID 20306254.
- ↑ 10.0 10.1 10.2 10.3 10.4 10.5 10.6 10.7 PST. 14 February 2011.
Further reading
Rowley JD (September 2008). "Chromosomal translocations: revisited yet again". Blood 112 (6): 2183–9. doi:10.1182/blood-2008-04-097931. PMID 18779403. http://bloodjournal.hematologylibrary.org/content/112/6/2183.full.